{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:29:38Z","timestamp":1772166578251,"version":"3.50.1"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100021078","name":"Norwegian Institute of Public Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100021078","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The risk of post-acute sequelae of COVID-19 (PASC) is estimated at 3\u20136% per infection in 2024. We hypothesized that widespread SARS-CoV-2 infections could lead to population-level consequences. Our previous study identified substantial increases in Norwegian primary healthcare consultations in 2023\u2014compared to pre-pandemic levels\u2014for conditions associated with acute COVID-19 and PASC. This study extended that analysis to 2024. We then assessed whether observed patterns were compatible with our hypothesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used data from the Norwegian Syndromic Surveillance System, which captures nationwide primary healthcare consultations for 102 ICPC-2 codes (out of a possible 710) that are relevant for infectious disease surveillance and some post-acute infection syndromes. Bayesian linear regression models were fitted to 2010\u20132019 trends, adjusting for population changes, to estimate expected values for 2024. Excess consultations were calculated by age and sex. A COVID-19 community spread was proxied by vaccination-adjusted weekly hospitalization rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 2024, there were 17,800,365 consultations, corresponding to an absolute excess of 1,185,231 consultations, or a 7.1% relative excess, compared to the modelled baseline. The 10 code combinations with largest absolute excess in 2024 were respiratory infections (325,726 excess consultations; 20% relative excess), fatigue (205,381; 70%), psychological symptom\/complaint other (188,978; 87%), acute stress reaction (182,079; 76%), feeling depressed (126,783; 133%), hyperkinetic disorder (112,763; 116%), abdominal pain\/cramps general (84,544; 29%), memory disturbance (39,177; 63%), conjunctivitis (34,643; 59%), and infectious disease other\/NOS (33,556; 81%). COVID-19 community spread showed the strongest correlations with conjunctivitis, strep throat, respiratory infections as a group (R**), fatigue, infectious disease other, memory disturbances, and pneumonia. Deviations from pre-pandemic trends varied: respiratory and psychological disorders worsened from 2020 onward and several conditions showed dramatic excess from 2022\u20132024. Females 15\u201329, children, adolescents, and young adults had disproportionately large relative excesses for consultations for memory disturbances.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Primary healthcare consultations in 2024 significantly exceeded pre-pandemic expectations, especially for conditions linked to acute COVID-19 and PASC, though the two cannot be differentiated in these data. While other factors undoubtedly also play a role, findings are compatible with ongoing population-level health impacts associated with repeated SARS-CoV-2 infections, particularly among women, children, adolescents, and young adults. These results emerged under a national COVID-19 strategy that does not account for post-acute consequences of SARS-CoV-2 infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13690-025-01817-8","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T06:30:59Z","timestamp":1767421859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Excess primary healthcare consultations in Norway in 2024 compared to pre-COVID-19-pandemic baseline trends"],"prefix":"10.1186","volume":"84","author":[{"given":"Richard Aubrey","family":"White","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz Valcarcel","family":"Salamanca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aslaug","family":"Angelsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinastry Pramadita","family":"Zakiudin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristomo","family":"Andries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunhild Alvik","family":"Nyborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"1817_CR1","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1016\/j.cell.2024.07.054","volume":"187","author":"MJ Peluso","year":"2024","unstructured":"Peluso MJ, Deeks SG. Mechanisms of long COVID and the path toward therapeutics. Cell. 2024;187:5500\u201329. https:\/\/doi.org\/10.1016\/j.cell.2024.07.054.","journal-title":"Cell"},{"key":"1817_CR2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7232a3","author":"ND Ford","year":"2023","unstructured":"Ford ND. Long COVID and significant activity limitation among adults, by age \u2014 United States, June 1\u201313, 2022, to June 7\u201319, 2023. MMWR Morb Mortal Wkly Rep. 2023. https:\/\/doi.org\/10.15585\/mmwr.mm7232a3.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"1817_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaf030","volume":"231","author":"SM Bartsch","year":"2025","unstructured":"Bartsch SM, Chin KL, Strych U, John DC, Shah TD, Bottazzi ME, et al. The current and future burden of long COVID in the United States. J Infect Dis. 2025;jiaf030. https:\/\/doi.org\/10.1093\/infdis\/jiaf030.","journal-title":"J Infect Dis"},{"key":"1817_CR4","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41577-023-00904-7","volume":"23","author":"DM Altmann","year":"2023","unstructured":"Altmann DM, Whettlock EM, Liu S, Arachchillage DJ, Boyton RJ. The immunology of long COVID. Nat Rev Immunol. 2023;23:618\u201334. https:\/\/doi.org\/10.1038\/s41577-023-00904-7.","journal-title":"Nat Rev Immunol"},{"key":"1817_CR5","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1038\/s41591-024-03173-6","volume":"30","author":"Z Al-Aly","year":"2024","unstructured":"Al-Aly Z, Davis H, McCorkell L, Soares L, Wulf-Hanson S, Iwasaki A, et al. Long COVID science, research and policy. Nat Med. 2024;30:2148\u201364. https:\/\/doi.org\/10.1038\/s41591-024-03173-6.","journal-title":"Nat Med"},{"issue":"4","key":"1817_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.5694\/mja2.52400","volume":"221","author":"V Costantino","year":"2024","unstructured":"Costantino V, Grafton Q, Kompas T, Chu L, Honeyman D, Notaras A, et al. The public health and economic burden of long <sc>COVID<\/sc>in Australia, 2022\u201324: a modelling study. Med J Aust. 2024;221(4):217\u201323. https:\/\/doi.org\/10.5694\/mja2.52400.","journal-title":"Med J Aust"},{"key":"1817_CR7","doi-asserted-by":"publisher","unstructured":"Kwon J, Mensah J, Milne R, Rayner C, Lawrence RR, De Kock J, et al. Health economic outcomes and national economic impacts associated with Long COVID in England and Scotland. Eur J Health Econ 2025 https:\/\/doi.org\/10.1007\/s10198-025-01788-1.","DOI":"10.1007\/s10198-025-01788-1"},{"key":"1817_CR8","unstructured":"Helse og omsorgsdepartementet. Regjeringens strategi og beredskapsplan for h\u00e5ndteringen av covid-19-pandemien (The government\u2019s strategy and preparedness plan for handling the COVID-19 pandemic). Regjeringen.no 2023. https:\/\/www.regjeringen.no\/no\/dokumentarkiv\/regjeringen-stoere\/andre-dokumenter\/hod\/2023\/regjeringens-strategi-og-beredskapsplan-for-handteringen-av-covid-19-pandemien\/id2987438\/. Accessed 27 Mar 2025."},{"key":"1817_CR9","unstructured":"World Health Organization. Clinical management of COVID-19: living guideline, 18 August 2023. World Health Organization; 2023."},{"key":"1817_CR10","unstructured":"Norwegian Institute of Public Health. Epidemier av luftveisinfeksjoner i Norge vinteren 2023\u201324: risiko, scenarioer og h\u00e5ndtering (Epidemics of respiratory infections in Norway in winter 2023\u201324: Risks, scenarios and handling) 2023."},{"key":"1817_CR11","unstructured":"Fausko L. FHI-overlege om coronatesting: \u2013 Jeg gidder ikke. VG 2023. https:\/\/www.vg.no\/nyheter\/i\/8JK78r\/fhi-om-coronatesting-jeg-gidder-ikke. Accessed 2 July 2025."},{"key":"1817_CR12","unstructured":"New-onset, self-reported long COVID after coronavirus (COVID-19) reinfection in the UK - Office for National Statistics n.d. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/conditionsanddiseases\/bulletins\/newonsetselfreportedlongcovidaftercoronaviruscovid19reinfectionintheuk\/23february2023. Accessed 27 May 2025."},{"key":"1817_CR13","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1038\/s41591-022-02051-3","volume":"28","author":"B Bowe","year":"2022","unstructured":"Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med. 2022;28:2398\u2013405. https:\/\/doi.org\/10.1038\/s41591-022-02051-3.","journal-title":"Nat Med"},{"key":"1817_CR14","unstructured":"Government of Canada SC. Experiences of Canadians with long-term symptoms following COVID-19 2023. https:\/\/www150.statcan.gc.ca\/n1\/pub\/75-006-x\/2023001\/article\/00015-eng.htm. Accessed 27 May 2025."},{"key":"1817_CR15","unstructured":"Todal PA. Med smitte skal landet vernast (Through infection, the country shall be protected) 2024. https:\/\/www.dagogtid.no\/samfunn\/med-smitte-skal-landet-vernast\/143147. Accessed 27 Mar 2025."},{"key":"1817_CR16","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S0140-6736(24)01136-X","volume":"404","author":"T Greenhalgh","year":"2024","unstructured":"Greenhalgh T, Sivan M, Perlowski A, Nikolich J\u017d. Long COVID: a clinical update. Lancet. 2024;404:707\u201324. https:\/\/doi.org\/10.1016\/S0140-6736(24)01136-X.","journal-title":"Lancet"},{"key":"1817_CR17","doi-asserted-by":"publisher","first-page":"126664","DOI":"10.1016\/j.vaccine.2024.126664","volume":"47","author":"IH Caspersen","year":"2025","unstructured":"Caspersen IH, Skodvin SN, Blix K, Robertson AH, Laake I, Feiring B, et al. Post-COVID symptoms after SARS-CoV-2 omicron infection and the effect of booster vaccination: a population-based cohort study. Vaccine. 2025;47:126664. https:\/\/doi.org\/10.1016\/j.vaccine.2024.126664.","journal-title":"Vaccine"},{"key":"1817_CR18","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1056\/NEJMoa2403211","volume":"391","author":"Y Xie","year":"2024","unstructured":"Xie Y, Choi T, Al-Aly Z. Postacute sequelae of SARS-CoV-2 infection in the pre-Delta, Delta, and Omicron eras. N Engl J Med. 2024;391:515\u201325. https:\/\/doi.org\/10.1056\/NEJMoa2403211.","journal-title":"N Engl J Med"},{"key":"1817_CR19","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1093\/aje\/kwad225","volume":"193","author":"L Spiliopoulos","year":"2024","unstructured":"Spiliopoulos L, S\u00f8rensen AIV, Bager P, Nielsen NM, Hansen JV, Koch A, et al. Postacute symptoms 4 months after SARS-CoV-2 infection during the Omicron period: a nationwide Danish questionnaire study. Am J Epidemiol. 2024;193:1106\u201314. https:\/\/doi.org\/10.1093\/aje\/kwad225.","journal-title":"Am J Epidemiol"},{"key":"1817_CR20","unstructured":"International Classification of Primary Care, 2nd edition (ICPC-2) n.d. https:\/\/www.who.int\/standards\/classifications\/other-classifications\/international-classification-of-primary-care. Accessed 2 June 2025."},{"key":"1817_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/fampra\/17.2.101","volume":"17","author":"I Okkes","year":"2000","unstructured":"Okkes I, Jamoulle M, Lamberts H, Bentzen N. ICPC-2-E: the electronic version of ICPC-2 differences from the printed version and the consequences. Fam Pract. 2000;17:101\u20137. https:\/\/doi.org\/10.1093\/fampra\/17.2.101.","journal-title":"Fam Pract"},{"key":"1817_CR22","unstructured":"Koderettleiing ved covid-19. Helsedirektoratet n.d. https:\/\/www.helsedirektoratet.no\/digitalisering-og-e-helse\/helsefaglige-kodeverk\/icpc\/koderettleiing-ved-covid-19. Accessed 2 June 2025."},{"key":"1817_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13690-024-01411-4","volume":"82","author":"RA White","year":"2024","unstructured":"White RA, Zhang C, Valcarcel Salamanca B, Angelsen A, Zakiudin DP, Andries A, et al. Aberrations in medically certified sick leave and primary healthcare consultations in Norway in 2023 compared to pre-COVID-19-pandemic trends. Arch Public Health. 2024;82:187. https:\/\/doi.org\/10.1186\/s13690-024-01411-4.","journal-title":"Arch Public Health"},{"key":"1817_CR24","unstructured":"World Health Organization. Ending the COVID-19 emergency and transitioning from emergency phase to longer-term disease management: Guidance on calibrating the response 2023. https:\/\/iris.who.int\/bitstream\/handle\/10665\/372712\/WHO-WHE-SPP-2023.2-eng.pdf?sequence=1. Accessed 21 July 2025."},{"key":"1817_CR25","doi-asserted-by":"publisher","first-page":"2101121","DOI":"10.2807\/1560-7917.ES.2022.27.43.2101121","volume":"27","author":"D Swanson","year":"2022","unstructured":"Swanson D, Koren C, Hopp P, Jonsson ME, R\u00f8 GI, White RA, et al. A one health real-time surveillance system for nowcasting Campylobacter gastrointestinal illness outbreaks, Norway, week 30 2010 to week 11 2022. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2022;27:2101121. https:\/\/doi.org\/10.2807\/1560-7917.ES.2022.27.43.2101121.","journal-title":"Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull"},{"key":"1817_CR26","unstructured":"Flere fastleger - regjeringen.no n.d. https:\/\/www.regjeringen.no\/no\/aktuelt\/flere-fastleger\/id3024659\/\u00a0.Accessed August 25, 2025."},{"key":"1817_CR27","unstructured":"Konsultasjoner med fastlege. Helsedirektoratet n.d. https:\/\/www.helsedirektoratet.no\/rapporter\/allmennlegetjenesten-arsrapport-2023-inklusive-status-per-mai-2024\/befolkningens-bruk-av-fastlege-og-legevakt\/konsultasjoner-med-fastlege. Accessed 10 Sept 2025."},{"key":"1817_CR28","unstructured":"Analyse- og kontrollrapporter fra Helfo. Helfo - Helseakt\u00f8rer n.d. https:\/\/www.helfo.no\/kontroll\/analyse-og-kontrollrapporter-fra-helfo. Accessed 25 Aug 2025."},{"key":"1817_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v080.i01","volume":"80","author":"P-C B\u00fcrkner","year":"2017","unstructured":"B\u00fcrkner P-C. brms: an R package for Bayesian multilevel models using Stan. J Stat Softw. 2017;80:1\u201328. https:\/\/doi.org\/10.18637\/jss.v080.i01.","journal-title":"J Stat Softw"},{"key":"1817_CR30","doi-asserted-by":"publisher","first-page":"395","DOI":"10.32614\/RJ-2018-017","volume":"10","author":"P-C B\u00fcrkner","year":"2018","unstructured":"B\u00fcrkner P-C. Advanced Bayesian multilevel modeling with the R package brms. R J. 2018;10:395\u2013411. https:\/\/doi.org\/10.32614\/RJ-2018-017.","journal-title":"R J"},{"key":"1817_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v100.i05","volume":"100","author":"P-C B\u00fcrkner","year":"2021","unstructured":"B\u00fcrkner P-C. Bayesian item response modeling in R with brms and Stan. J Stat Softw. 2021;100:1\u201354. https:\/\/doi.org\/10.18637\/jss.v100.i05.","journal-title":"J Stat Softw"},{"key":"1817_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s44298-023-00011-3","volume":"2","author":"CK Yinda","year":"2024","unstructured":"Yinda CK, Port JR, Bushmaker T, Schulz JE, Gallogly S, Fischer RJ, et al. Airborne transmission efficiency of SARS-CoV-2 in Syrian hamsters is not influenced by environmental conditions. NPJ Viruses. 2024;2:2. https:\/\/doi.org\/10.1038\/s44298-023-00011-3.","journal-title":"NPJ Viruses"},{"key":"1817_CR33","doi-asserted-by":"publisher","DOI":"10.3201\/eid3108.250451","author":"EB Rose","year":"2025","unstructured":"Rose EB, Paden CR, Cook PW, Ma KC, Winn A, Castro J, et al. Estimated COVID-19 periodicity and correlation with SARS-CoV-2 spike protein S1 antigenic diversity, United States. Emerg Infect Dis. 2025. https:\/\/doi.org\/10.3201\/eid3108.250451.","journal-title":"Emerg Infect Dis"},{"key":"1817_CR34","unstructured":"JCVI statement on COVID-19 vaccination in 2025 and spring 2026. GOVUK n.d. https:\/\/www.gov.uk\/government\/publications\/covid-19-vaccination-in-2025-and-spring-2026-jcvi-advice\/jcvi-statement-on-covid-19-vaccination-in-2025-and-spring-2026. Accessed 15 Oct 2025."},{"key":"1817_CR35","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2024","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2024."},{"key":"1817_CR36","doi-asserted-by":"publisher","unstructured":"White RA. org: Organising Projects 2019:2024.6.5. https:\/\/doi.org\/10.32614\/CRAN.package.org.","DOI":"10.32614\/CRAN.package.org"},{"key":"1817_CR37","doi-asserted-by":"publisher","unstructured":"White RA. plnr: A System for Planing Analyses 2022:2022.11.23. https:\/\/doi.org\/10.32614\/CRAN.package.plnr.","DOI":"10.32614\/CRAN.package.plnr"},{"key":"1817_CR38","unstructured":"Vogt H. Medier og forskere maler fanden p\u00e5 veggen om \u00ablangvarig covid-19\u00bb og kronisk utmattelse 2020. https:\/\/www.aftenposten.no\/meninger\/kronikk\/i\/opdB6a\/en-fryktdrevet-pandemi-av-varige-helseproblemer. Accessed 2 July 2025."},{"key":"1817_CR39","unstructured":"Vogt H. En fryktdrevet pandemi av varige helseproblemer 2020."},{"key":"1817_CR40","unstructured":"Olaisen SR. Legar seier korona kan vare kortare om ein ikkje er redd: \u2013 Kjipt \u00e5 h\u00f8yre. NRK 2022. https:\/\/www.nrk.no\/nordland\/frykt-for-korona-forlenger-forlopet_-meiner-lege.-kognitive-teknikkar-kan-vere-ei-loysing-1.15837918. Accessed 2 July 2025."},{"key":"1817_CR41","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1080\/02813432.2023.2235609","volume":"41","author":"TN Alme","year":"2023","unstructured":"Alme TN, Andreasson A, Asprusten TT, Bakken AK, Beadsworth MB, Boye B, et al. Chronic fatigue syndromes: real illnesses that people can recover from. Scand J Prim Health Care. 2023;41:372\u20136. https:\/\/doi.org\/10.1080\/02813432.2023.2235609.","journal-title":"Scand J Prim Health Care"},{"key":"1817_CR42","unstructured":"Wyller VBB. 3.29 Senf\u00f8lger etter COVID-19 (\u00abLong COVID\u00bb) hos barn og ungdommer under 18 \u00e5r \u2013 diagnostikk, behandling og henvisningsrutiner. Helsebiblioteket n.d. https:\/\/www.helsebiblioteket.no\/innhold\/retningslinjer\/pediatri\/generell-veileder-i-pediatri\/3.infeksjoner-vaksiner-og-undersokelse-av-adoptivbarn\/3.29-senfolger-etter-covid-19-long-covid-hos-barn-og-ungdommer-under-18-ar--diagnostikk-behandling-og-henvisningsrutiner. Accessed 10 Sept 2025."},{"key":"1817_CR43","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1126\/science.adn1077","volume":"383","author":"W Ruf","year":"2024","unstructured":"Ruf W. Immune damage in long covid. Science. 2024;383:262\u20133. https:\/\/doi.org\/10.1126\/science.adn1077.","journal-title":"Science"},{"key":"1817_CR44","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140491","author":"JK Files","year":"2021","unstructured":"Files JK, Boppana S, Perez MD, Sarkar S, Lowman KE, Qin K, et al. Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/JCI140491.","journal-title":"J Clin Invest"},{"key":"1817_CR45","doi-asserted-by":"publisher","unstructured":"Cai M, Xu E, Xie Y, Al-Aly Z. Rates of infection with other pathogens after a positive COVID-19 test versus a negative test in US veterans (November, 2021, to December, 2023): a retrospective cohort study. Lancet Infect Dis. 2025(8). https:\/\/doi.org\/10.1016\/S1473-3099(24)00831-4.","DOI":"10.1016\/S1473-3099(24)00831-4"},{"key":"1817_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/fmch-2023-002456","volume":"11","author":"L Wang","year":"2023","unstructured":"Wang L, Davis PB, Berger N, Kaelber DC, Volkow N, Xu R. Association of COVID-19 with respiratory syncytial virus (RSV) infections in children aged 0\u20135 years in the USA in 2022: a multicentre retrospective cohort study. Fam Med Community Health. 2023;11:e002456. https:\/\/doi.org\/10.1136\/fmch-2023-002456.","journal-title":"Fam Med Community Health"},{"key":"1817_CR47","doi-asserted-by":"publisher","first-page":"e072529","DOI":"10.1136\/bmj-2022-072529","volume":"380","author":"B Mizrahi","year":"2023","unstructured":"Mizrahi B, Sudry T, Flaks-Manov N, Yehezkelli Y, Kalkstein N, Akiva P, et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ. 2023;380:e072529. https:\/\/doi.org\/10.1136\/bmj-2022-072529.","journal-title":"BMJ"},{"key":"1817_CR48","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2024.29.20.2400242","volume":"29","author":"BV Salamanca","year":"2024","unstructured":"Salamanca BV, Cyr PR, Bentdal YE, Watle SV, Wester AL, Strand \u00c5MW, et al. Increase in invasive group A streptococcal infections (iGAS) in children and older adults, Norway, 2022 to 2024. Euro Surveill. 2024;29:2400242. https:\/\/doi.org\/10.2807\/1560-7917.ES.2024.29.20.2400242.","journal-title":"Euro Surveill"},{"key":"1817_CR49","doi-asserted-by":"publisher","unstructured":"Mahesh T, Changela S, Duong KS, Henry S, Wang SH, Duong TQ. New-onset conjunctivitis 3.5 years post SARS-CoV-2 infection in an inner-city population in the Bronx. BMJ Open Ophthalmol 2025;10 https:\/\/doi.org\/10.1136\/bmjophth-2024-001993.","DOI":"10.1136\/bmjophth-2024-001993"},{"key":"1817_CR50","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1038\/s41467-025-59012-w","volume":"16","author":"LL O\u2019Mahoney","year":"2025","unstructured":"O\u2019Mahoney LL, Routen A, Gillies C, Jenkins SA, Almaqhawi A, Ayoubkhani D, et al. The risk of long Covid symptoms: a systematic review and meta-analysis of controlled studies. Nat Commun. 2025;16:4249. https:\/\/doi.org\/10.1038\/s41467-025-59012-w.","journal-title":"Nat Commun"},{"key":"1817_CR51","doi-asserted-by":"publisher","first-page":"e941","DOI":"10.1093\/infdis\/jiaf133","volume":"231","author":"P Hedberg","year":"2025","unstructured":"Hedberg P, van der Werff SD, Naucl\u00e9r P. The effect of COVID-19 vaccination on the risk of persistent post\u2013COVID-19 condition: cohort study. J Infect Dis. 2025;231:e941-4. https:\/\/doi.org\/10.1093\/infdis\/jiaf133.","journal-title":"J Infect Dis"},{"key":"1817_CR52","unstructured":"Jan Lippestad, Nanna Kurtze, Anne Mette Bjerkan. Status for helse- og omsorgstilbudet til pasienter med CFS\/ME i Norge. SINTEF; 2011."},{"key":"1817_CR53","first-page":"25","volume":"2023","author":"LL Moberg","year":"2023","unstructured":"Moberg LL, Kabash S. Sykefrav\u00e6r etter covid-19. Arb Og Velferd. 2023;2023:25\u201340.","journal-title":"Arb Og Velferd"},{"key":"1817_CR54","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s11606-024-09290-9","volume":"40","author":"SD Vernon","year":"2025","unstructured":"Vernon SD, Zheng T, Do H, Marconi VC, Jason LA, Singer NG, et al. Incidence and prevalence of post-COVID-19 myalgic encephalomyelitis: a report from the observational RECOVER-adult study. J Gen Intern Med. 2025;40:1085\u201394. https:\/\/doi.org\/10.1007\/s11606-024-09290-9.","journal-title":"J Gen Intern Med"},{"key":"1817_CR55","doi-asserted-by":"publisher","first-page":"e0277317","DOI":"10.1371\/journal.pone.0277317","volume":"17","author":"M Pantelic","year":"2022","unstructured":"Pantelic M, Ziauddeen N, Boyes M, O\u2019Hara ME, Hastie C, Alwan NA. Long Covid stigma: estimating burden and validating scale in a UK-based sample. PLoS One. 2022;17:e0277317. https:\/\/doi.org\/10.1371\/journal.pone.0277317.","journal-title":"PLoS One"},{"key":"1817_CR56","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s12916-025-04335-0","volume":"23","author":"R B\u00fcchner","year":"2025","unstructured":"B\u00fcchner R, Sander C, Schindler S, Walter M, Scheibenbogen C, Schomerus G. \u201cHave you considered that it could be burnout?\u201d\u2014psychologization and stigmatization of self-reported long COVID or post-COVID-19 vaccination syndrome. BMC Med. 2025;23:488. https:\/\/doi.org\/10.1186\/s12916-025-04335-0.","journal-title":"BMC Med"},{"key":"1817_CR57","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S2215-0366(22)00260-7","volume":"9","author":"M Taquet","year":"2022","unstructured":"Taquet M, Sillett R, Zhu L, Mendel J, Camplisson I, Dercon Q, et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry. 2022;9:815\u201327. https:\/\/doi.org\/10.1016\/S2215-0366(22)00260-7.","journal-title":"Lancet Psychiatry"},{"key":"1817_CR58","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S2215-0366(21)00084-5","volume":"8","author":"M Taquet","year":"2021","unstructured":"Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416\u201327. https:\/\/doi.org\/10.1016\/S2215-0366(21)00084-5.","journal-title":"Lancet Psychiatry"},{"key":"1817_CR59","doi-asserted-by":"publisher","unstructured":"Moen JK, Baker CA, Iwasaki A. Neuroimmune pathophysiology of long COVID. Psychiatry Clin Neurosci n.d.;n\/a. https:\/\/doi.org\/10.1111\/pcn.13855","DOI":"10.1111\/pcn.13855"},{"key":"1817_CR60","unstructured":"Helsedirektoratet. FinnKode - P29 n.d. https:\/\/finnkode.helsedirektoratet.no\/icpc2\/chapter\/P29?q=slitenhet. Accessed 27 May 2025."},{"key":"1817_CR61","unstructured":"Utbrenthet (P29 Psykiske symptomer\/plager). Helsedirektoratet n.d. https:\/\/www.helsedirektoratet.no\/veiledere\/sykmelderveileder\/diagnosespesifikke-anbefalinger-for-sykmelding\/psykisk-p\/utbrenthet-p29-psykiske-symptomerplager. Accessed 27 May 2025."},{"key":"1817_CR62","unstructured":"Helsedirektoratet. FinnKode - P02 n.d. https:\/\/finnkode.helsedirektoratet.no\/icpc2\/chapter\/P02?q=p02. Accessed 27 May 2025."},{"key":"1817_CR63","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1080\/03007995.2022.2081454","volume":"38","author":"SV Sylvester","year":"2022","unstructured":"Sylvester SV, Rusu R, Chan B, Bellows M, O\u2019Keefe C, Nicholson S. Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review. Curr Med Res Opin. 2022;38:1391\u20139. https:\/\/doi.org\/10.1080\/03007995.2022.2081454.","journal-title":"Curr Med Res Opin"},{"key":"1817_CR64","doi-asserted-by":"publisher","first-page":"e2455430","DOI":"10.1001\/jamanetworkopen.2024.55430","volume":"8","author":"DP Shah","year":"2025","unstructured":"Shah DP, Thaweethai T, Karlson EW, Bonilla H, Horne BD, Mullington JM, et al. Sex differences in long COVID. JAMA Netw Open. 2025;8:e2455430. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.55430.","journal-title":"JAMA Netw Open"},{"key":"1817_CR65","doi-asserted-by":"publisher","unstructured":"Silva J, Takahashi T, Wood J, Lu P, Tabachnikova A, Gehlhausen JR, et al. Sex differences in symptomatology and immune profiles of Long COVID 2024. https:\/\/doi.org\/10.1101\/2024.02.29.24303568.","DOI":"10.1101\/2024.02.29.24303568"},{"key":"1817_CR66","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1001\/jama.2022.18931","volume":"328","author":"S Wulf Hanson","year":"2022","unstructured":"Global Burden of Disease Long COVID Collaborators, Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604. https:\/\/doi.org\/10.1001\/jama.2022.18931.","journal-title":"JAMA"},{"key":"1817_CR67","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)31561-0","volume":"396","author":"F Mauvais-Jarvis","year":"2020","unstructured":"Mauvais-Jarvis F, Bairey Merz N, Barnes PJ, Brinton RD, Carrero J-J, DeMeo DL, et al. Sex and gender: modifiers of health, disease, and medicine. Lancet. 2020;396:565\u201382. https:\/\/doi.org\/10.1016\/S0140-6736(20)31561-0.","journal-title":"Lancet"},{"key":"1817_CR68","unstructured":"Bakken A. Ungdata 2024. Nasjonale resultater. NOVA\/OsloMet; 2024."},{"key":"1817_CR69","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1038\/s41598-025-85919-x","volume":"15","author":"J Charles James","year":"2025","unstructured":"Charles James J, Schulze H, Siems N, Prehn C, Quast DR, Trampe N, et al. Neurological post-COVID syndrome is associated with substantial impairment of verbal short-term and working memory. Sci Rep. 2025;15:1695. https:\/\/doi.org\/10.1038\/s41598-025-85919-x.","journal-title":"Sci Rep"},{"key":"1817_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2024.100857","volume":"41","author":"S Buer","year":"2024","unstructured":"Buer S, Hagen BI, S\u00f8raas A, White RA, B\u00f8 R, Ellingjord-Dale M, et al. Executive deficits after SARS-CoV-2 infection: a cross-sectional population study. Brain, Behavior, & Immunity - Health. 2024;41:100857. https:\/\/doi.org\/10.1016\/j.bbih.2024.100857.","journal-title":"Brain, Behavior, & Immunity - Health"},{"key":"1817_CR71","unstructured":"Psykiske plager og lidelser hos barn og unge. Folkehelseinstituttet 2024. https:\/\/www.fhi.no\/he\/fr\/folkehelserapporten\/psykisk-helse\/psykisk-helse-hos-barn-og-unge\/\u00a0. Accessed July 17, 2025."},{"key":"1817_CR72","unstructured":"Nossen JP, Delalic L. Hvorfor er sykefrav\u00e6ret fortsatt h\u00f8yt 3\u20134 \u00e5r etter starten av pandemien? | Arbeid og velferd. Arb Og Velferd n.d.;2024."},{"key":"1817_CR73","unstructured":"Abdominal pain patterns during COVID-19: an observational study | Scientific Reports n.d. https:\/\/www.nature.com\/articles\/s41598-022-18753-0. Accessed 12 Sept 2025."},{"key":"1817_CR74","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133\u201346. https:\/\/doi.org\/10.1038\/s41579-022-00846-2.","journal-title":"Nat Rev Microbiol"},{"key":"1817_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1455295","author":"KH Lee","year":"2024","unstructured":"Lee KH, Kim YO, Dho SH, Yong JJH, Oh H-S, Lee JH, et al. Altered gut microbiome in convalescent patients with coronavirus disease 2019. Front Cell Infect Microbiol. 2024. https:\/\/doi.org\/10.3389\/fcimb.2024.1455295.","journal-title":"Front Cell Infect Microbiol"},{"key":"1817_CR76","doi-asserted-by":"publisher","DOI":"10.1111\/all.16593","author":"J Rohrhofer","year":"2025","unstructured":"Rohrhofer J, Wolflehner V, Schweighardt J, Koidl L, Stingl M, Zehetmayer S, et al. Gastrointestinal barrier disruption in post-COVID syndrome fatigue patients. Allergy. 2025. https:\/\/doi.org\/10.1111\/all.16593.","journal-title":"Allergy"},{"key":"1817_CR77","unstructured":"Hu K, Patel J, Swiston C, Patel BC. Ophthalmic Manifestations of Coronavirus (COVID-19). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025."},{"key":"1817_CR78","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1323","volume":"12","author":"H Pourriyahi","year":"2024","unstructured":"Pourriyahi H, Hajizadeh N, Khosravi M, Pourriahi H, Soleimani S, Hosseini NS, et al. New variants of COVID-19 (XBB.1.5 and XBB.1.16, the \u201cArcturus\u201d): a review of highly questioned concerns, a brief comparison between different peaks in the COVID-19 pandemic, with a focused systematic review on expert recommendations for prevention, vaccination, and treatment measures in the general population and at-risk groups. Immunity Inflamm Dis. 2024;12:e1323. https:\/\/doi.org\/10.1002\/iid3.1323.","journal-title":"Immunity Inflamm Dis"},{"key":"1817_CR79","doi-asserted-by":"publisher","first-page":"e2023062570","DOI":"10.1542\/peds.2023-062570","volume":"153","author":"S Rao","year":"2024","unstructured":"Rao S, Gross RS, Mohandas S, Stein CR, Case A, Dreyer B, et al. Postacute sequelae of SARS-CoV-2 in children. Pediatrics. 2024;153:e2023062570. https:\/\/doi.org\/10.1542\/peds.2023-062570.","journal-title":"Pediatrics"},{"key":"1817_CR80","unstructured":"Jelstad J. Forskere krever bedre inneklima i skoler: FHI: \u2013 Mangler kunnskap om effekten av god ventilasjon 2022. https:\/\/www.utdanningsnytt.no\/fhi-forfall-forskning\/forskere-krever-bedre-inneklima-i-skoler-fhi-mangler-kunnskap-om-effekten-av-god-ventilasjon\/335272. Accessed 23 May 2025."},{"key":"1817_CR81","unstructured":"Folkehelseinstituttet. Svar p\u00e5 oppdrag B1 i forel\u00f8pig tildelingsbrev - Forslag til m\u00e5lgrupper for koronavaksinasjonsprogrammet i 2024 2024. https:\/\/www.fhi.no\/contentassets\/1af4c6e655014a738055c79b72396de8\/svar-pa-oppdrag-b1-i-forelopig-tildelingsbrev---forslag-til-malgrupper-for-koronavaksinasjonsprogrammet-i-2024_sladdet.pdf. Accessed 15 July 2025."},{"key":"1817_CR82","unstructured":"Koronavaksine - Vaksineanbefalinger for sesong 2024\/2025. Folkehelseinstituttet 2024. https:\/\/www.fhi.no\/ss\/korona\/koronavaksinasjonsprogrammet\/koronavaksine\/. Accessed 22 May 2025."},{"key":"1817_CR83","unstructured":"Helse-og omsorgsdepartementet. Koronavaksinasjon av barn og unge. Regjeringen.no 2022. https:\/\/www.regjeringen.no\/no\/aktuelt\/koronavaksinasjon-av-barn-og-unge\/id2895513\/. Accessed 23 May 2025."},{"key":"1817_CR84","doi-asserted-by":"publisher","first-page":"e2459672","DOI":"10.1001\/jamanetworkopen.2024.59672","volume":"8","author":"AR Yousaf","year":"2025","unstructured":"Yousaf AR, Mak J, Gwynn L, Lutrick K, Bloodworth RF, Rai RP, et al. COVID-19 vaccination and odds of post\u2013COVID-19 condition symptoms in children aged 5 to 17 years. JAMA Netw Open. 2025;8:e2459672. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.59672.","journal-title":"JAMA Netw Open"},{"key":"1817_CR85","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1038\/s41598-024-84140-6","volume":"15","author":"J H\u00f6ppner","year":"2025","unstructured":"H\u00f6ppner J, Maier C, Schlegtendal A, Hoffmann A, Petersmann A, L\u00fccke T, et al. Long-term effects of SARS-CoV-2 infection and vaccination in a population-based pediatric cohort. Sci Rep. 2025;15:2921. https:\/\/doi.org\/10.1038\/s41598-024-84140-6.","journal-title":"Sci Rep"},{"key":"1817_CR86","doi-asserted-by":"publisher","unstructured":"White RA, Nygaard AB, S\u00f8raas A, Nyborg GA. Excess all-cause mortality in Norway in 2024. Scand J Public Health 2025;0:14034948251371830. https:\/\/doi.org\/10.1177\/14034948251371830.","DOI":"10.1177\/14034948251371830"},{"key":"1817_CR87","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/s41591-024-02987-8","volume":"30","author":"M Cai","year":"2024","unstructured":"Cai M, Xie Y, Topol EJ, Al-Aly Z. Three-year outcomes of post-acute sequelae of COVID-19. Nat Med. 2024;30:1564\u201373. https:\/\/doi.org\/10.1038\/s41591-024-02987-8.","journal-title":"Nat Med"},{"key":"1817_CR88","unstructured":"White RA, Nyborg GA. The long shadow of COVID-19 on Norwegian sick leave and primary healthcare consultations. Nor Epidemiol 2025."},{"key":"1817_CR89","doi-asserted-by":"publisher","unstructured":"Eurostat. Life expectancy by age and sex 2022. https:\/\/doi.org\/10.2908\/DEMO_MLEXPEC.","DOI":"10.2908\/DEMO_MLEXPEC"},{"key":"1817_CR90","unstructured":"Centro de Investigaciones Sociol\u00f3gicas. Estudio: 3470 - BAR\u00d3METRO SANITARIO 2024 (SEGUNDA OLEADA). CIS n.d. https:\/\/www.cis.es\/detalle-ficha-estudio?origen=estudio&idEstudio=14838. Accessed 2 June 2025."},{"key":"1817_CR91","unstructured":"Centro de Investigaciones Sociol\u00f3gicas. Estudio: 3357 - BAR\u00d3METRO SANITARIO 2022 (PRIMERA OLEADA). CIS n.d. https:\/\/www.cis.es\/detalle-ficha-estudio?origen=estudio&idEstudio=14619. Accessed 2 June 2025."},{"key":"1817_CR92","unstructured":"Centro de Investigaciones Sociol\u00f3gicas. Estudio: 3266 - BAR\u00d3METRO SANITARIO 2019 (TERCERA OLEADA). CIS n.d. https:\/\/www.cis.es\/detalle-ficha-estudio?origen=estudio&idEstudio=14477. Accessed 2 June 2025."},{"key":"1817_CR93","unstructured":"Centro de Investigaciones Sociol\u00f3gicas. Estudio: 2946 - BAR\u00d3METRO SANITARIO 2012 (SEGUNDA OLEADA). CIS n.d. https:\/\/www.cis.es\/detalle-ficha-estudio?origen=estudio&idEstudio=14085. Accessed 2 June 2025."},{"key":"1817_CR94","unstructured":"Federal Reserve Bank of St. Louis. Population - With a Disability, 16 Years and over 2025. https:\/\/fred.stlouisfed.org\/series\/LNU00074597. Accessed 2 June 2025."},{"key":"1817_CR95","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1007\/s00787-022-02034-2","volume":"32","author":"AMS S\u00f8rensen","year":"2023","unstructured":"S\u00f8rensen AMS, Wesselh\u00f6eft R, Andersen JH, Reutfors J, Cesta CE, Furu K, et al. Trends in use of attention deficit hyperactivity disorder medication among children and adolescents in Scandinavia in 2010\u20132020. Eur Child Adolesc Psychiatry. 2023;32:2049\u201356. https:\/\/doi.org\/10.1007\/s00787-022-02034-2.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"1817_CR96","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1111\/apa.70129","volume":"114","author":"I Engstr\u00f6m","year":"2025","unstructured":"Engstr\u00f6m I. Explosive increase in diagnosis and treatment of ADHD in Sweden may be related to private health providers offering fast-track, guaranteed diagnoses. Acta Paediatr. 2025;114:2095\u20137. https:\/\/doi.org\/10.1111\/apa.70129.","journal-title":"Acta Paediatr"},{"key":"1817_CR97","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/acps.13719","volume":"150","author":"H Kildegaard","year":"2024","unstructured":"Kildegaard H, Wesselhoeft R, Lund LC, Bliddal M. Post-pandemic trends in psychotropic medication use in Danish children, adolescents, and young adults. Acta Psychiatr Scand. 2024;150:174\u20137. https:\/\/doi.org\/10.1111\/acps.13719.","journal-title":"Acta Psychiatr Scand"},{"key":"1817_CR98","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"AJ Ferrari","year":"2024","unstructured":"Ferrari AJ, Santomauro DF, Aali A, Abate YH, Abbafati C, Abbastabar H, et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:2133\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(24)00757-8.","journal-title":"Lancet"},{"key":"1817_CR99","doi-asserted-by":"publisher","first-page":"e0003406","DOI":"10.1371\/journal.pgph.0003406","volume":"4","author":"K Tu","year":"2024","unstructured":"Tu K, Lapadula MC, Apajee J, Bonilla AO, Baste V, Cuba-Fuentes MS, et al. Changes in reasons for visits to primary care after the start of the COVID-19 pandemic: an international comparative study by the International Consortium of Primary Care Big Data Researchers (INTRePID). PLoS Glob Public Health. 2024;4:e0003406. https:\/\/doi.org\/10.1371\/journal.pgph.0003406.","journal-title":"PLoS Glob Public Health"},{"key":"1817_CR100","doi-asserted-by":"publisher","DOI":"10.1787\/83363382-en","volume-title":"OECD Economic Outlook, Volume 2025 Issue 1: Preliminary version","author":"OECD","year":"2025","unstructured":"OECD. OECD Economic Outlook, Volume 2025 Issue 1: Preliminary version, vol. 2025. OECD Publishing; 2025. https:\/\/doi.org\/10.1787\/83363382-en."},{"key":"1817_CR101","unstructured":"Helfo kontroll. Kontroll av n\u00e6ringsdrivende fastlegers refusjonskrav for e-konsultasjone n.d. https:\/\/www.helfo.no\/kontroll\/analyse-og-kontrollrapporter-fra-helfo\/Kontrollrapport%20e-konsultasjoner%202024.pdf\/_\/attachment\/inline\/8fa41d08-55bd-442c-8b33-77f965baa715:c23fb18d2fffd26e7dc857e0a3368672b87b3866\/Kontrollrapport%20e-konsultasjoner%202024.pdf. Accessed 10 Sept 2025."}],"container-title":["Archives of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13690-025-01817-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-025-01817-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-025-01817-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T14:09:34Z","timestamp":1770041374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13690-025-01817-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1817"],"URL":"https:\/\/doi.org\/10.1186\/s13690-025-01817-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7184987\/v1","asserted-by":"object"}]},"ISSN":["2049-3258"],"issn-type":[{"value":"2049-3258","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. All data are aggregate registry data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RAW and BVS are employed by the Norwegian Institute of Public Health, which is responsible for providing guidance and recommendations regarding COVID-19 in Norway.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}